|
⚲
|
| Keyboard |
| Moin Andrew
✚
|
|
|---|---|
| CIK # | 0001996040 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001996040] | |
| 4 | [0001996040] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| SAB Biotherapeutics Inc | |
| Moin Andrew |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-09-29 | Option exercise | 17,400 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2025-09-29 | Option exercise | 1,740,000 | $1.75 | 3,045,000 |
|
SAB Biotherapeutics Inc SABS
Warrants (right to buy) · derivative
|
2025-07-22 | Grant | 114,250 | ||
|
SAB Biotherapeutics Inc SABS
Series B Convertible Preferred Stock · derivative
|
2025-07-22 | Grant | 228,500 | ||
|
SAB Biotherapeutics Inc SABS
Warrants (right to buy) · derivative
|
2025-07-22 | Grant | 228,500 | ||
|
SAB Biotherapeutics Inc SABS
Common Stock
|
2023-11-24 | Option exercise | 4,584,571 | ||
|
SAB Biotherapeutics Inc SABS
Series A-2 Convertible Preferred Stock · derivative
|
2023-11-24 | Option exercise | 28,380 | $1,000.00 | 28,380,000 |
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-11-24 | Option exercise | 31,269 | $1,000.00 | 31,269,000 |
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-11-13 | Grant | 13,269 | $1,000.00 | 13,269,000 |
|
SAB Biotherapeutics Inc SABS
Preferred Tranche A Warrants · derivative
|
2023-11-13 | Option exercise | 13,269 | ||
|
SAB Biotherapeutics Inc SABS
Preferred Tranche B Warrants · derivative
|
2023-11-10 | Grant | 8,846 | ||
|
SAB Biotherapeutics Inc SABS
Preferred Tranche C Warrants · derivative
|
2023-11-10 | Grant | 22,115 | ||
|
SAB Biotherapeutics Inc SABS
Preferred Tranche A Warrants · derivative
|
2023-11-10 | Grant | 13,269 | ||
|
SAB Biotherapeutics Inc SABS
Preferred Tranche A Warrants · derivative
|
2023-10-23 | Option exercise | 16,269 | ||
|
SAB Biotherapeutics Inc SABS
Series A-1 Convertible Preferred Stock · derivative
|
2023-10-23 | Grant | 16,269 | $1,000.00 | 16,269,000 |